Mobile Cardiac Telemetry Systems Market Size & Growth Report to 2030

Key Findings:

• The market size was valued at ~ US$ 1 Bn in 2023 and experiencing a significant growth rate of over 11.5% by 2030
• By disease indication, the heart failure segment dominated the market in the benchmark year 2023
• Geographically, the North America is accounted to hold the largest revenue share of over 1/3 market in the benchmark year 2023

The global mobile cardiac telemetry systems market size was valued at around USD 1 billion in 2023 and anticipated to register a significant CAGR of over 11.5% during the forecast period from 2024 to 2030. The market has seen substantial growth due to the increasing demand for continuous cardiac monitoring solutions. These systems provide real-time data on patients’ heart activity, helping to detect conditions like arrhythmias, ischemic events, and other heart abnormalities that might be missed in traditional monitoring. The development of lightweight, compact, and discreet devices has made them more suitable for long-term use, ensuring greater patient comfort and compliance. Additionally, these systems are finding expanded applications, particularly in managing complex cardiac conditions, offering more personalized care and enabling earlier intervention, which is crucial for improving patient outcomes​.

Technological advancements and a growing preference for homecare and outpatient monitoring are expected to drive the market further. Lead-based MCTS systems remain popular for their proven accuracy and reliability, but patch-based systems are gaining traction due to their ease of use and comfort for patients. Hospitals, diagnostic centers, and specialty clinics are the key end-users, but the adoption of these systems in homecare settings is increasing as well. The high prevalence of cardiovascular diseases and rising awareness about the benefits of continuous monitoring are further propelling market expansion, particularly in regions such as North America and Europe​.

Market Snapshot:

To know more about the research study, request sample papers

Market Drivers:

Rising Prevalence of Cardiovascular Diseases (CVDs): Cardiovascular diseases, including arrhythmias, ischemic heart disease, and hypertension, are becoming more prevalent globally, especially among aging populations. These conditions often require constant monitoring to detect irregularities or heart-related events early, making MCTS systems an essential tool in healthcare. The ability of MCTS to provide real-time, continuous monitoring allows healthcare providers to intervene quickly, improving patient outcomes and reducing the need for hospitalization. The World Health Organization (WHO) reports that CVDs remain the leading cause of death worldwide, further driving the demand for efficient and non-invasive monitoring solutions​.Furthermore, the Centers for Disease Control and Prevention (CDC) estimates that by 2030, approximately 12.1 million people in the United States will be affected by atrial fibrillation (AF), a common heart arrhythmia that can lead to serious complications such as stroke and heart failure​.

Technological Advancements: The ongoing evolution of MCTS technology is a significant driver in the market. Advances have led to the development of smaller, more efficient, and patient-friendly devices that are easier to wear and use. These systems are more accurate in detecting cardiac abnormalities, offering enhanced comfort for patients, which helps improve compliance with long-term monitoring. Furthermore, the ability to monitor heart activity remotely has enhanced the appeal of these systems. With better data transmission technologies, MCTS can now seamlessly integrate with healthcare systems for quicker, more accurate diagnoses​.

Aging Population: The global population is aging, and older individuals are more susceptible to cardiovascular conditions. As the population aged 65 and older continues to grow, the need for ongoing health monitoring becomes increasingly important. MCTS systems provide a non-invasive and effective solution for elderly patients, enabling them to monitor their heart health remotely. This is particularly important for those with chronic conditions or those who prefer not to be in a hospital environment. The global aging trend is contributing to a larger market for mobile cardiac monitoring solutions​.

Preference for Home Healthcare: The growing trend towards home healthcare and outpatient monitoring is another critical factor propelling the MCTS market. Patients increasingly prefer being monitored at home, as this allows them to maintain a higher quality of life while still receiving the necessary healthcare. MCTS systems enable doctors to monitor patients remotely and receive real-time updates on their condition, significantly reducing the need for frequent hospital visits. This shift towards home healthcare has made mobile cardiac telemetry systems more accessible and essential, particularly for patients with chronic heart conditions or those in recovery​.

Increased Awareness and Focus on Preventive Healthcare: As healthcare shifts from reactive to preventive care, there is a growing awareness of the importance of continuous health monitoring. People are more proactive about maintaining their heart health, which includes using tools like MCTS for early detection of potential problems. Early intervention can prevent complications, reduce hospital admissions, and ultimately improve patient health outcomes. This trend is leading to greater demand for cardiac telemetry systems as more individuals seek to take control of their heart health.

Market Trends:

The global mobile cardiac telemetry systems market is witnessing significant advancements in real-time monitoring technology. One of the key trends is the increased adoption of wireless and cloud-based solutions. These technologies allow for continuous, remote monitoring of patients’ heart conditions, enabling quicker responses to critical events. Moreover, the integration of artificial intelligence (AI) and machine learning (ML) algorithms is enhancing the predictive capabilities of these systems, improving diagnostic accuracy and enabling better long-term care management. The ease of integration with electronic health records (EHR) further accelerates the adoption of these devices in healthcare settings, allowing for more streamlined patient management and data analysis​.

Another major trend in the mobile cardiac telemetry systems market is the growing shift toward patient-centered care. As healthcare systems focus more on personalized treatment plans, mobile cardiac telemetry devices are increasingly seen as an essential tool for managing chronic conditions such as atrial fibrillation and heart failure. These devices offer patients the convenience of at-home monitoring, reducing the need for frequent hospital visits and empowering them to take an active role in their health management. The rise in telemedicine and virtual consultations, especially following the COVID-19 pandemic, has further amplified the demand for such mobile monitoring devices. As a result, healthcare providers are increasingly incorporating these systems to enhance patient care, reduce costs, and improve overall clinical outcomes​.

Market Opportunities:

The global mobile cardiac telemetry systems market is experiencing significant opportunities due to the rising prevalence of cardiovascular diseases (CVDs) and the growing demand for remote healthcare solutions. According to the World Health Organization (WHO), CVDs are the leading cause of death globally, claiming an estimated 17.9 million lives annually. With such a high disease burden, healthcare systems are increasingly adopting mobile cardiac telemetry solutions to provide continuous and accurate monitoring of patients’ heart conditions. These systems not only enable early detection of arrhythmias or other anomalies but also allow patients to stay at home, reducing hospital visits and minimizing the burden on healthcare facilities. The COVID-19 pandemic has also accelerated the adoption of telemedicine and remote monitoring technologies, further expanding opportunities for mobile cardiac telemetry systems.​

Another significant opportunity for growth in the market is the ongoing advancements in artificial intelligence (AI) and machine learning (ML) integration into cardiac telemetry systems. By incorporating AI and ML, these systems can offer predictive analytics, allowing healthcare providers to anticipate potential cardiac events before they occur, thus improving patient outcomes. For instance, AI-powered systems can analyze vast amounts of real-time data to detect patterns that might be missed by human clinicians. This opportunity is particularly critical in managing high-risk patients with chronic conditions such as atrial fibrillation, where early detection of irregularities can be life-saving. As AI and ML technologies continue to evolve, the potential for enhancing the capabilities of mobile cardiac telemetry systems is expected to drive widespread adoption, particularly in emerging markets that are increasingly focusing on improving healthcare infrastructure.

Market Restraints:

The growth of the global mobile cardiac telemetry systems market faces several restraining factors, primarily related to high implementation costs and the complexity of integrating new technologies into existing healthcare infrastructures. The initial costs for purchasing, maintaining, and upgrading mobile cardiac telemetry devices can be prohibitively expensive for many healthcare providers, especially in emerging markets. Additionally, integrating these systems with existing electronic health record (EHR) systems and hospital infrastructure can be technologically challenging and resource-intensive, causing delays in adoption. Furthermore, data privacy and security concerns remain significant barriers, as the transmission of sensitive health data over wireless and cloud platforms raises concerns about potential breaches and cyberattacks. The need to comply with strict regulatory requirements for patient data protection, such as HIPAA in the United States and GDPR in Europe, further complicates market expansion.

Market Insights:

The global mobile cardiac telemetry systems market is bifurcated into disease indication, application, end-user, and geography. On the basis of disease indication, the heart failure segment is the dominant driver in the market in 2023. Heart failure, characterized by the heart’s inability to pump blood efficiently, affects millions of people globally. According to the American Heart Association, more than 6 million adults in the United States are living with heart failure, and the number is expected to rise as the population ages. Mobile cardiac telemetry systems are increasingly adopted to monitor heart function continuously, providing critical data for clinicians to detect early signs of worsening symptoms. These systems help reduce hospital readmissions and improve patient management by offering real-time alerts to healthcare providers about potential heart failure exacerbations​.

The prevalence of heart failure is a key reason for its dominance in the market, as the condition often requires long-term management and monitoring. With the growing aging population and increasing rates of cardiovascular diseases, the need for continuous cardiac monitoring solutions is expanding. Mobile cardiac telemetry devices allow for non-invasive, remote monitoring, enabling patients to manage their heart failure from the comfort of their home while reducing the burden on healthcare facilities. The adoption of these devices is expected to continue to grow, especially in developed markets with high healthcare infrastructure, due to their effectiveness in preventing complications and improving patient outcomes.

Market Trends for Heart Failure Sub-category:

• One of the key trends in the Heart Failure sub-category is the increasing integration of advanced technology, such as artificial intelligence (AI) and machine learning (ML), into mobile cardiac telemetry systems. These technologies enable predictive analytics, which can help healthcare providers identify early warning signs of worsening heart failure before they become critical. For instance, AI-driven systems can analyze real-time data from cardiac telemetry devices to predict heart failure exacerbations, enabling timely interventions. With the increasing focus on preventative care and personalized treatment plans, AI and ML are becoming integral components of mobile cardiac monitoring solutions​.
• Another important trend is the growing adoption of wearable cardiac monitoring devices, which are capable of providing continuous, real-time heart function data. These wearables are particularly beneficial for heart failure patients who need constant monitoring. By allowing for at-home monitoring, these devices reduce the need for frequent hospital visits, improving patient convenience and quality of life. The integration of telemedicine into cardiac care is another important trend, as it enables doctors to remotely monitor patients and adjust treatment plans without requiring face-to-face consultations, offering more flexible care options. As heart failure cases continue to rise globally, especially in aging populations, the demand for these advanced mobile cardiac telemetry systems is expected to keep increasing​.

Market Opportunities for the Heart Failure Sub-Category:

• One major opportunity lies in expanding the availability of mobile cardiac telemetry systems in emerging markets, where healthcare access and infrastructure may be limited. As healthcare systems in developing countries improve, the demand for affordable, effective heart failure management solutions will rise. Mobile cardiac telemetry offers a cost-effective solution to monitor patients remotely, reducing the strain on healthcare facilities and enabling more efficient use of resources. According to a report by the World Health Organization (WHO), heart failure rates are rising not only in developed nations but also in emerging economies, creating a significant opportunity for growth in these regions​.
• Additionally, collaborations and partnerships between medical device companies and digital health tech startups present significant opportunities for innovation in the heart failure segment. Companies can develop more sophisticated, integrated systems that combine mobile cardiac telemetry with other health management tools, such as telemedicine platforms and mobile health apps, to provide a comprehensive heart failure care solution. The combination of remote monitoring, real-time data, and AI-driven insights has the potential to revolutionize how heart failure is managed, creating new revenue streams and improving patient outcomes globally.

The mobile cardiac telemetry systems market research report presents the analysis of each segment from 2020 to 2030 considering 2023 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2024 to 2030.

Historical & Forecast Period

• 2020-22 – Historical Year
• 2023 – Base Year
• 2024-2030 – Forecast Period

Market Segmentation:

By Disease Indication:

• Angina Pectoris
• Atherosclerosis
• Heart Failure
• Others

By Application:

• Lead-based
• Patch-based

By End-User:

• Hospitals
• Specialty Clinics
• Diagnostic Centers
• Home Care Settings
• Others

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Regional Analysis:

Geographically, the North America is the dominant region in the global mobile cardiac telemetry systems market, primarily due to its well-established healthcare infrastructure, high adoption of advanced medical technologies, and a large patient population dealing with heart-related conditions. The U.S. is a key player in this market, accounting for the largest market share. A report from the American Heart Association (AHA) indicates that over 18 million Americans suffer from heart disease, including a significant proportion from heart failure, thus increasing the demand for continuous heart monitoring solutions. Furthermore, the U.S. healthcare system is highly receptive to the adoption of innovative medical technologies, including mobile cardiac telemetry, which offers continuous monitoring of patients at risk of cardiovascular complications. This market demand is further fueled by a shift toward more personalized, patient-centered care and remote health monitoring solutions​.

The region also benefits from significant investments in research and development (R&D) for new and improved cardiac monitoring technologies. Companies operating in North America, such as Medtronic, Philips Healthcare, and Boston Scientific, are actively developing next-generation telemetry systems integrated with artificial intelligence (AI) and machine learning (ML) to enhance heart failure management. The presence of a large number of healthcare institutions and the growing aging population in North America have contributed to the market’s growth. According to the Centers for Disease Control and Prevention (CDC), by 2030, an estimated 12.1 million people in the U.S. will have atrial fibrillation, which further increases the demand for advanced cardiac monitoring technologies like mobile telemetry systems. The region’s dominance is expected to continue throughout the forecast period, driven by both technological innovation and the aging population.

Competitive Landscape:

Some of the prominent market players operating in the global mobile cardiac telemetry systems market are BioTelemetry, Inc., ScottCare, Biotricity, Inc., Welch Allyn, and Applied Cardiac Systems, Inc. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

Key Companies:

• BioTelemetry, Inc.
• ScottCare
• Biotricity, Inc.
• Welch Allyn
• Applied Cardiac Systems, Inc.
• Medicomp, Inc.
• Preventice Solutions
• Telerhythmics LLC
• Zoll Medical Corporation
• iRhythm Technologies, Inc.

Key Questions Answered by Mobile Cardiac Telemetry Systems Market Report

• Global mobile cardiac telemetry systems market forecasts from 2024-2030
• Regional market forecasts from 2024-2030 covering Asia-Pacific, North America, Europe, Middle East & Africa, and Latin America
• Country-level forecasts from 2024-2030 covering 15 major countries from the regions as mentioned above
• Mobile cardiac telemetry systems submarket forecasts from 2024-2030 covering the market by disease indication, application, end-user, and geography
• Various industry models such as SWOT analysis, Value Chain Analysis about the market
• Analysis of the key factors driving and restraining the growth of the global, regional, and country-level mobile cardiac telemetry systems markets from 2024-2030
• Competitive Landscape and market positioning of top 10 players operating in the market